Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenovirus
New adenovirus research from University of Groningen, Department of Clinical Pharmacology outlined
March 2nd, 2008
Investigators publish new data in the report 'Adenovirus-mediated interleukin-13 gene therapy attenuates acute kidney allograft injury.' "Kidney transplantation is possible by virtue of systemic immunosuppression, which is in turn accompanied by serious side effects. The search for novel therapeutic agents and strategies is ongoing," scientists in Netherlands report. "Here we investigate the effects of adenovirus-mediated gene therapy with interleukin (IL)-13, which is a cytokine with strong immunomodulatory properties, on acute renal allograft injury. In addition, we compare the effects of local (intrarenal) and systemic (intramuscular) IL-13 gene therapy in kidney...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-02)
|
